ERD

A genome‐wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS ‐mutant melano...

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Melanoma models for the next generation of therapies

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Periodic Reporting for period 4 - MEL-Interactions (An integrative approach for the exploration of melanoma genetic and ...

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

MEK inhibition reverses aberrant signaling in melanoma cells through reorganization of NRas and BRAF in self nano-cluste...

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Mechanisms of immune activation and regulation: lessons from melanoma

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Intratumor heterogeneity and anti-tumor immunity shape one another bidirectionally

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Large-Scale Immuno-Peptidome Analysis Reveals Recurrent Post-Translational Splicing of Cancer and Immune-Associated Gene...

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

PhISCS-BnB: a fast branch and bound algorithm for the perfect tumor phylogeny reconstruction problem.

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

PIK3CA in cancer: The past 30 years

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSC...

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Anti-tumour immunity induces aberrant peptide presentation in melanoma

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Cross-Talk between Receptor Tyrosine Kinases AXL and ERBB3 Regulates Invadopodia Formation in Melanoma Cells

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

NRas activity is regulated by dynamic interactions with nanoscale signaling clusters at the plasma membrane

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Neoantigens in cancer immunotherapy: quantity vs. quality

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Cancer research in the era of immunogenomics

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

The landscape of T cell antigens for cancer immunotherapy

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Identification of bacteria-derived HLA-bound peptides in melanoma

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Ca...

Project: MEL-Interactions

Updated at: 27-04-2024

Show more information

Project acronym MEL-Interactions

Resources

Selected filters:

A genome‐wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS ‐mutant melano...

Melanoma models for the next generation of therapies

Periodic Reporting for period 4 - MEL-Interactions (An integrative approach for the exploration of melanoma genetic and ...

UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma

MEK inhibition reverses aberrant signaling in melanoma cells through reorganization of NRas and BRAF in self nano-cluste...

Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma

Mechanisms of immune activation and regulation: lessons from melanoma

Intratumor heterogeneity and anti-tumor immunity shape one another bidirectionally

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics

Large-Scale Immuno-Peptidome Analysis Reveals Recurrent Post-Translational Splicing of Cancer and Immune-Associated Gene...

PhISCS-BnB: a fast branch and bound algorithm for the perfect tumor phylogeny reconstruction problem.

PIK3CA in cancer: The past 30 years

Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma

The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSC...

Anti-tumour immunity induces aberrant peptide presentation in melanoma

Cross-Talk between Receptor Tyrosine Kinases AXL and ERBB3 Regulates Invadopodia Formation in Melanoma Cells

NRas activity is regulated by dynamic interactions with nanoscale signaling clusters at the plasma membrane

Neoantigens in cancer immunotherapy: quantity vs. quality

Cancer research in the era of immunogenomics

The landscape of T cell antigens for cancer immunotherapy

Identification of bacteria-derived HLA-bound peptides in melanoma

Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors

Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Ca...